Surprisingly, as the passage of the tumor-derived cells (TDCs) increased, the expressions of stem cell markers such as Oct4, CD133, and Sox2 decreased rapidly while the expression levels of oncogenes including c-Myc, Klf4 and ABCG2 were maintained (Supplementary Fig. S5). This evidence concerns the gene SOX2 and neoplasm.